During the development of fatty liver-associated comorbidities such as T2D and obesity, the liver secretes large amounts of VLDL particles [29] that eventually lead to elevated levels of plasma FA uptake through lipase activity (LPL) [30]. This evidence concerns the gene LPL and type 2 diabetes mellitus.